Overall, COVID-19 data show lower levels of blood IFN-α in critically ill patients (requiring IV), compared to the COVID-19 patients requiring only oxygen supplementation (p = 0.03—Supplementary Figure 1A). This evidence concerns the gene IFNA1 and COVID-19.